Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-05 1:40 pm Purchase | 2025-12-31 | 13G | Vor Biopharma Inc. VOR | FMR LLC | 2,526,170 6.500% | 1,737,723 (+220.40%) | Filing History |
| 2025-12-23 4:05 pm Purchase | 2025-12-18 | 13D | Vor Biopharma Inc. VOR | ForGrowth III PA B.V. | 10,237,714 9.990% | 3,237,714 (+46.25%) | Filing History |
| 2025-12-19 4:40 pm Purchase | 2025-12-18 | 13G | Vor Biopharma Inc. VOR | Frazier Life Sciences Public Fund, L.P. | 2,258,001 5.800% | 2,258,001 (New Position) | Filing History |
| 2025-12-18 6:31 pm Purchase | 2025-12-18 | 13D | Vor Biopharma Inc. VOR | RA CAPITAL MANAGEMENT L.P. | 5,411,521 14.000% | 3,066,244 (+130.74%) | Filing History |
| 2025-12-17 4:00 pm Purchase | 2025-12-10 | 13G | Vor Biopharma Inc. VOR | Great Point Partners, LLC | 1,234,486 5.630% | 1,234,486 (New Position) | Filing History |
| 2025-11-18 4:30 pm Purchase | 2025-11-11 | 13G | Vor Biopharma Inc. VOR | Paradigm BioCapital Advisors LP | 1,750,000 8.600% | 1,750,000 (New Position) | Filing History |
| 2025-11-14 6:13 pm Purchase | 2025-11-12 | 13D | Vor Biopharma Inc. VOR | RA CAPITAL MANAGEMENT L.P. | 2,345,277 9.900% | 1,534,606 (+189.30%) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | Vor Biopharma Inc. VOR | FMR LLC | 788,447 11.500% | 788,447 (New Position) | Filing History |
| 2025-11-05 4:14 pm Purchase | 2025-09-18 | 13G | Vor Biopharma Inc. VOR | Qiming Venture Partners VIII Investments, LLC | 496,272 5.440% | 496,272 (New Position) | Filing History |
| 2025-10-30 6:42 pm Sale | 2025-10-28 | 13D | Vor Biopharma Inc. VOR | RA CAPITAL MANAGEMENT L.P. | 810,671 11.500% | -375,829 (-31.68%) | Filing History |
| 2025-10-27 8:06 pm Sale | 2025-10-23 | 13D | Vor Biopharma Inc. VOR | RA CAPITAL MANAGEMENT L.P. | 1,186,500 17.300% | -246,193 (-17.18%) | Filing History |
| 2025-10-20 6:58 pm Sale | 2025-10-16 | 13D | Vor Biopharma Inc. VOR | RA CAPITAL MANAGEMENT L.P. | 1,432,693 20.900% | -555,964 (-27.96%) | Filing History |
| 2025-10-17 6:36 pm Purchase | 2025-10-15 | 13D | Vor Biopharma Inc. VOR | Reprogrammed Interchange LLC | 1,204,442 17.600% | 1,204,442 (New Position) | Filing History |
| 2025-10-16 4:45 pm Sale | 2025-10-14 | 13D | Vor Biopharma Inc. VOR | Reprogrammed Interchange LLC | 1,278,118 18.600% | -96,657 (-7.03%) | Filing History |
| 2025-10-10 5:52 pm Sale | 2025-10-08 | 13D | Vor Biopharma Inc. VOR | Reprogrammed Interchange LLC | 1,374,775 20.100% | -124,146 (-8.28%) | Filing History |
| 2025-10-08 5:24 pm Sale | 2025-10-06 | 13D | Vor Biopharma Inc. VOR | Reprogrammed Interchange LLC | 1,498,921 21.900% | -98,387 (-6.16%) | Filing History |
| 2025-10-06 5:20 pm Sale | 2025-10-02 | 13D | Vor Biopharma Inc. VOR | Reprogrammed Interchange LLC | 1,597,308 23.300% | -99,116 (-5.84%) | Filing History |
| 2025-09-26 08:18 am Purchase | 2025-09-18 | 13G | Vor Biopharma Inc. VOR | Verve Capital Limited | 760,699 9.900% | 760,699 (New Position) | Filing History |
| 2025-09-25 8:34 pm Purchase | 2025-09-18 | 13G | Vor Biopharma Inc. VOR | Venrock Healthcare Capital Partners III, L.P. | 760,699 9.900% | 760,699 (New Position) | Filing History |
| 2025-09-23 4:00 pm Purchase | 2025-09-18 | 13G | Vor Biopharma Inc. VOR | ForGrowth III PA B.V. | 7,000,000 9.990% | 7,000,000 (New Position) | Filing History |